Global Angiotensin Receptor Blockers (ARBs) Market Research Report 2020

Publisher Name :
Date: 25-Mar-2020
No. of pages: 123
Inquire Before Buying

The global Angiotensin Receptor Blockers (ARBs) market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.

This report focuses on Angiotensin Receptor Blockers (ARBs) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Angiotensin Receptor Blockers (ARBs) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Angiotensin Receptor Blockers (ARBs) market is segmented into

- Valsartan

- Telmisartan

- Losartan

- Irbesartan

- Azilsartan

- Olmesartan

Segment by Application

- Hypertension

- Cardiovascular Diseases

- Kidney Diseases

- Other

Global Angiotensin Receptor Blockers (ARBs) Market: Regional Analysis

The Angiotensin Receptor Blockers (ARBs) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Angiotensin Receptor Blockers (ARBs) market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Angiotensin Receptor Blockers (ARBs) Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Angiotensin Receptor Blockers (ARBs) market include:

- Pfizer

- Novartis

- Merck

- Astra Zeneca

- Jhonson and Johnson

- Eli Lilly

- Sanofi

- Bristol-Myers Squibb

- Bayer

- GSK

- Teva Pharmaceutical

Global Angiotensin Receptor Blockers (ARBs) Market Research Report 2020

Table of Contents
1 Angiotensin Receptor Blockers (ARBs) Market Overview
1.1 Product Overview and Scope of Angiotensin Receptor Blockers (ARBs)
1.2 Angiotensin Receptor Blockers (ARBs) Segment by Type
1.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 Angiotensin Receptor Blockers (ARBs) Segment by Application
1.3.1 Angiotensin Receptor Blockers (ARBs) Sales Comparison by Application: 2020 VS 2026
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Global Angiotensin Receptor Blockers (ARBs) Market Size Estimates and Forecasts
1.4.1 Global Angiotensin Receptor Blockers (ARBs) Revenue 2015-2026
1.4.2 Global Angiotensin Receptor Blockers (ARBs) Sales 2015-2026
1.4.3 Angiotensin Receptor Blockers (ARBs) Market Size by Region: 2020 Versus 2026
2 Global Angiotensin Receptor Blockers (ARBs) Market Competition by Manufacturers
2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Manufacturers (2015-2020)
2.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Angiotensin Receptor Blockers (ARBs) Manufacturing Sites, Area Served, Product Type
2.5 Angiotensin Receptor Blockers (ARBs) Market Competitive Situation and Trends
2.5.1 Angiotensin Receptor Blockers (ARBs) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Angiotensin Receptor Blockers (ARBs) Players (Opinion Leaders)
3 Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario by Region
3.1 Global Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
3.3.1 North America Angiotensin Receptor Blockers (ARBs) Sales by Country
3.3.2 North America Angiotensin Receptor Blockers (ARBs) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
3.4.1 Europe Angiotensin Receptor Blockers (ARBs) Sales by Country
3.4.2 Europe Angiotensin Receptor Blockers (ARBs) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Region
3.5.1 Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales by Region
3.5.2 Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
3.6.1 Latin America Angiotensin Receptor Blockers (ARBs) Sales by Country
3.6.2 Latin America Angiotensin Receptor Blockers (ARBs) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
3.7.1 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales by Country
3.7.2 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Angiotensin Receptor Blockers (ARBs) Historic Market Analysis by Type
4.1 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2015-2020)
4.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Type (2015-2020)
4.3 Global Angiotensin Receptor Blockers (ARBs) Price Market Share by Type (2015-2020)
4.4 Global Angiotensin Receptor Blockers (ARBs) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Angiotensin Receptor Blockers (ARBs) Historic Market Analysis by Application
5.1 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2015-2020)
5.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Application (2015-2020)
5.3 Global Angiotensin Receptor Blockers (ARBs) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Angiotensin Receptor Blockers (ARBs) Business
6.1 Pfizer
6.1.1 Corporation Information
6.1.2 Pfizer Description, Business Overview and Total Revenue
6.1.3 Pfizer Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Pfizer Products Offered
6.1.5 Pfizer Recent Development
6.2 Novartis
6.2.1 Novartis Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
6.2.2 Novartis Description, Business Overview and Total Revenue
6.2.3 Novartis Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Novartis Products Offered
6.2.5 Novartis Recent Development
6.3 Merck
6.3.1 Merck Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
6.3.2 Merck Description, Business Overview and Total Revenue
6.3.3 Merck Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Merck Products Offered
6.3.5 Merck Recent Development
6.4 Astra Zeneca
6.4.1 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
6.4.2 Astra Zeneca Description, Business Overview and Total Revenue
6.4.3 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Astra Zeneca Products Offered
6.4.5 Astra Zeneca Recent Development
6.5 Jhonson and Johnson
6.5.1 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
6.5.2 Jhonson and Johnson Description, Business Overview and Total Revenue
6.5.3 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Jhonson and Johnson Products Offered
6.5.5 Jhonson and Johnson Recent Development
6.6 Eli Lilly
6.6.1 Eli Lilly Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
6.6.2 Eli Lilly Description, Business Overview and Total Revenue
6.6.3 Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Eli Lilly Products Offered
6.6.5 Eli Lilly Recent Development
6.7 Sanofi
6.6.1 Sanofi Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
6.6.2 Sanofi Description, Business Overview and Total Revenue
6.6.3 Sanofi Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Products Offered
6.7.5 Sanofi Recent Development
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
6.8.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.8.3 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Bristol-Myers Squibb Products Offered
6.8.5 Bristol-Myers Squibb Recent Development
6.9 Bayer
6.9.1 Bayer Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
6.9.2 Bayer Description, Business Overview and Total Revenue
6.9.3 Bayer Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Bayer Products Offered
6.9.5 Bayer Recent Development
6.10 GSK
6.10.1 GSK Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
6.10.2 GSK Description, Business Overview and Total Revenue
6.10.3 GSK Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.10.4 GSK Products Offered
6.10.5 GSK Recent Development
6.11 Teva Pharmaceutical
6.11.1 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
6.11.2 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Description, Business Overview and Total Revenue
6.11.3 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Teva Pharmaceutical Products Offered
6.11.5 Teva Pharmaceutical Recent Development
7 Angiotensin Receptor Blockers (ARBs) Manufacturing Cost Analysis
7.1 Angiotensin Receptor Blockers (ARBs) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
7.4 Angiotensin Receptor Blockers (ARBs) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Angiotensin Receptor Blockers (ARBs) Distributors List
8.3 Angiotensin Receptor Blockers (ARBs) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Angiotensin Receptor Blockers (ARBs) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Angiotensin Receptor Blockers (ARBs) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Angiotensin Receptor Blockers (ARBs) by Type (2021-2026)
10.2 Angiotensin Receptor Blockers (ARBs) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Angiotensin Receptor Blockers (ARBs) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Angiotensin Receptor Blockers (ARBs) by Application (2021-2026)
10.3 Angiotensin Receptor Blockers (ARBs) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Angiotensin Receptor Blockers (ARBs) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Angiotensin Receptor Blockers (ARBs) by Region (2021-2026)
10.4 North America Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2021-2026)
10.5 Europe Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2021-2026)
10.6 Asia Pacific Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2021-2026)
10.7 Latin America Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Angiotensin Receptor Blockers (ARBs) Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Angiotensin Receptor Blockers (ARBs) Manufacturers Covered in This Study
Table 5. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Manufacturers (2015-2020)
Table 7. Global Angiotensin Receptor Blockers (ARBs) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Angiotensin Receptor Blockers (ARBs) Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Angiotensin Receptor Blockers (ARBs) Sales Sites and Area Served
Table 11. Manufacturers Angiotensin Receptor Blockers (ARBs) Product Types
Table 12. Global Angiotensin Receptor Blockers (ARBs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Angiotensin Receptor Blockers (ARBs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin Receptor Blockers (ARBs) as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Angiotensin Receptor Blockers (ARBs) Players
Table 16. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Region (2015-2020)
Table 17. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2015-2020)
Table 18. Global Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region (2015-2020)
Table 20. North America Angiotensin Receptor Blockers (ARBs) Sales by Country (2015-2020) (K MT)
Table 21. North America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2015-2020)
Table 22. North America Angiotensin Receptor Blockers (ARBs) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2015-2020)
Table 24. Europe Angiotensin Receptor Blockers (ARBs) Sales by Country (2015-2020) (K MT)
Table 25. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2015-2020)
Table 26. Europe Angiotensin Receptor Blockers (ARBs) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Angiotensin Receptor Blockers (ARBs) Sales by Country (2015-2020) (K MT)
Table 33. Latin America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2015-2020)
Table 34. Latin America Angiotensin Receptor Blockers (ARBs) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2015-2020)
Table 40. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Type (2015-2020)
Table 41. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Type (2015-2020)
Table 42. Global Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Type (2015-2020)
Table 44. Global Angiotensin Receptor Blockers (ARBs) Price (USD/Unit) by Type (2015-2020)
Table 45. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Application (2015-2020)
Table 46. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2015-2020)
Table 47. Global Angiotensin Receptor Blockers (ARBs) Sales Growth Rate by Application (2015-2020)
Table 48. Pfizer Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Pfizer Main Product
Table 52. Pfizer Recent Development
Table 53. Novartis Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 54. Novartis Corporation Information
Table 55. Novartis Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Novartis Main Product
Table 57. Novartis Recent Development
Table 58. Merck Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 59. Merck Corporation Information
Table 60. Merck Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Merck Main Product
Table 62. Merck Recent Development
Table 63. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 64. Astra Zeneca Corporation Information
Table 65. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Astra Zeneca Main Product
Table 67. Astra Zeneca Recent Development
Table 68. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 69. Jhonson and Johnson Corporation Information
Table 70. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Jhonson and Johnson Main Product
Table 72. Jhonson and Johnson Recent Development
Table 73. Eli Lilly Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 74. Eli Lilly Corporation Information
Table 75. Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Eli Lilly Main Product
Table 77. Eli Lilly Recent Development
Table 78. Sanofi Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 79. Sanofi Corporation Information
Table 80. Sanofi Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Sanofi Main Product
Table 82. Sanofi Recent Development
Table 83. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 84. Bristol-Myers Squibb Corporation Information
Table 85. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Bristol-Myers Squibb Main Product
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Bayer Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 89. Bayer Corporation Information
Table 90. Bayer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Bayer Main Product
Table 92. Bayer Recent Development
Table 93. GSK Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 94. GSK Corporation Information
Table 95. GSK Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. GSK Main Product
Table 97. GSK Recent Development
Table 98. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Corporation Information
Table 99. Teva Pharmaceutical Corporation Information
Table 100. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Teva Pharmaceutical Main Product
Table 102. Teva Pharmaceutical Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Angiotensin Receptor Blockers (ARBs) Distributors List
Table 106. Angiotensin Receptor Blockers (ARBs) Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) Forecast by Type (2021-2026)
Table 111. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) Forecast by Application (2021-2026)
Table 115. Global Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) Forecast by Region (2021-2026)
Table 117. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Angiotensin Receptor Blockers (ARBs)
Figure 2. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type: 2020 VS 2026
Figure 3. Valsartan Product Picture
Figure 4. Telmisartan Product Picture
Figure 5. Losartan Product Picture
Figure 6. Irbesartan Product Picture
Figure 7. Azilsartan Product Picture
Figure 8. Olmesartan Product Picture
Figure 9. Global Angiotensin Receptor Blockers (ARBs) Consumption Market Share by Application: 2020 VS 2026
Figure 10. Hypertension
Figure 11. Cardiovascular Diseases
Figure 12. Kidney Diseases
Figure 13. Other
Figure 14. Global Angiotensin Receptor Blockers (ARBs) Market Size 2015-2026 (US$ Million)
Figure 15. Global Angiotensin Receptor Blockers (ARBs) Sales Capacity (K MT) (2015-2026)
Figure 16. Global Angiotensin Receptor Blockers (ARBs) Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Angiotensin Receptor Blockers (ARBs) Sales Share by Manufacturers in 2020
Figure 18. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Manufacturers in 2019
Figure 19. The Global 5 and 10 Largest Players: Market Share by Angiotensin Receptor Blockers (ARBs) Revenue in 2019
Figure 20. Angiotensin Receptor Blockers (ARBs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2015-2020)
Figure 22. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region in 2019
Figure 23. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region (2015-2020)
Figure 24. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region in 2019
Figure 25. North America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country in 2019
Figure 26. North America Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country in 2019
Figure 27. U.S. Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 28. U.S. Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Canada Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 30. Canada Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country in 2019
Figure 32. Europe Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country in 2019
Figure 33. Germany Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 34. Germany Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. France Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 36. France Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. U.K. Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 38. U.K. Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Italy Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 40. Italy Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Russia Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 42. Russia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region in 2019
Figure 44. Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region in 2019
Figure 45. China Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 46. China Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Japan Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 48. Japan Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. South Korea Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 50. South Korea Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. India Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 52. India Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Australia Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 54. Australia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Taiwan Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 56. Taiwan Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Indonesia Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 58. Indonesia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Thailand Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 60. Thailand Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Malaysia Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 62. Malaysia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Philippines Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 64. Philippines Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Vietnam Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 66. Vietnam Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Latin America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country in 2019
Figure 68. Latin America Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country in 2019
Figure 69. Mexico Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 70. Mexico Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Brazil Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 72. Brazil Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Argentina Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 74. Argentina Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country in 2019
Figure 76. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country in 2019
Figure 77. Turkey Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 78. Turkey Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Saudi Arabia Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 80. Saudi Arabia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. U.A.E Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 82. U.A.E Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Sales Market Share of Angiotensin Receptor Blockers (ARBs) by Type (2015-2020)
Figure 84. Sales Market Share of Angiotensin Receptor Blockers (ARBs) by Type in 2019
Figure 85. Revenue Share of Angiotensin Receptor Blockers (ARBs) by Type (2015-2020)
Figure 86. Revenue Market Share of Angiotensin Receptor Blockers (ARBs) by Type in 2019
Figure 87. Global Angiotensin Receptor Blockers (ARBs) Sales Growth by Type (2015-2020) (K MT)
Figure 88. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2015-2020)
Figure 89. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application in 2019
Figure 90. Global Revenue Share of Angiotensin Receptor Blockers (ARBs) by Application (2015-2020)
Figure 91. Global Revenue Share of Angiotensin Receptor Blockers (ARBs) by Application in 2020
Figure 92. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Astra Zeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Jhonson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Price Trend of Key Raw Materials
Figure 104. Manufacturing Cost Structure of Angiotensin Receptor Blockers (ARBs)
Figure 105. Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
Figure 106. Angiotensin Receptor Blockers (ARBs) Industrial Chain Analysis
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Porter's Five Forces Analysis
Figure 110. North America Angiotensin Receptor Blockers (ARBs) Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 111. North America Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Europe Angiotensin Receptor Blockers (ARBs) Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 113. Europe Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Latin America Angiotensin Receptor Blockers (ARBs) Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 115. Latin America Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 117. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 119. Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
  • Global Epoetin-alfa Erythropoietin Market Status and Future Forecast 2015-2025
    Published: 05-Apr-2020        Price: US 4500 Onwards        Pages: 121
    Summary The report forecast global Epoetin-alfa Erythropoietin market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Epoetin-alfa Erythropoietin industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Epoetin-alfa Erythropoietin by geography. The report splits the mark......
  • Global Empty Capsules Market Status and Future Forecast 2015-2025
    Published: 05-Apr-2020        Price: US 4500 Onwards        Pages: 117
    Summary The report forecast global Empty Capsules market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Empty Capsules industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Empty Capsules by geography. The report splits the market size, by volume and value, on the ba......
  • Global OSDF Excipients Market Research Report 2015-2025
    Published: 05-Apr-2020        Price: US 1800 Onwards        Pages: 88
    Summary The global OSDF Excipients market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as foll......
  • Global Pharmaceutical Excipients Market Research Report 2015-2025
    Published: 04-Apr-2020        Price: US 2060 Onwards        Pages: 92
    Summary Pharmaceutical Excipients Excipients are crucial to drug delivery within the body. Generally, an excipient has no medicinal properties. Its standard purpose is to streamline the manufacture of the drug product and ultimately facilitate physiological absorption of the drug. Excipients might aid in lubricity, flowability, disintegration, taste and may confer some form of antimicrobial function. Selecting the appropriate excipient to support the design of your pharmaceutical ......
  • Global 7-Aminocephalosporanic Acid (7-ACA) Market Research Report 2015-2025
    Published: 04-Apr-2020        Price: US 1800 Onwards        Pages: 86
    Summary The global 7-Aminocephalosporanic Acid (7-ACA) market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Produc......
  • Global Anti-Rheumatics Market Forecast 2020-2028
    Published: 03-Apr-2020        Price: US 2500 Onwards        Pages: 168
    KEY FINDINGS The global anti-rheumatics market is anticipated to record a CAGR of 2.32% during the projected period of 2020-2028. The factors that offer lucrative growth opportunities include a surge in the geriatric population all over the world, an increase in the incidences of obesity, a rise in awareness related to early screening and treatment of rheumatoid arthritis. MARKET INSIGHTS Rheumatoid arthritis is a chronic inflammatory medical condition, which causes ......
  • North America Anti-Rheumatics Market Forecast 2020-2028
    Published: 03-Apr-2020        Price: US 1250 Onwards        Pages: 113
    KEY FINDINGS The North America anti-rheumatics market is estimated to witness considerable growth and record a CAGR of 2.63% over the forecast period, 2020-2028. One of the significant factors propelling market growth is the presence of major key players such as Merck & Co., Inc, AbbVie Inc, Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc, and Pfizer, Inc augments market growth. MARKET INSIGHTS In order to study the growth of the North America anti-rhe......
  • Europe Anti-Rheumatics Market Forecast 2020-2028
    Published: 03-Apr-2020        Price: US 1250 Onwards        Pages: 115
    KEY FINDINGS The Europe anti-rheumatics market is predicted to reach a CAGR of 2.10% over the forecast period of 2020-2028. A huge patient base of rheumatoid arthritis, owing to a large geriatric population, is one of the crucial factors favoring the market growth in the region. MARKET INSIGHTS The Europe anti-rheumatics market is researched further by segmenting the region into countries such as France, Russia, the UK, Poland, Germany, Belgium, Italy, and the rest o......
  • Asia Pacific Anti-Rheumatic Market Forecast 2020-2028
    Published: 03-Apr-2020        Price: US 1250 Onwards        Pages: 111
    KEY FINDINGS The Asia Pacific anti-rheumatics market is estimated to record a CAGR of 2.38% during the forecast period of 2020-2028. A surge in healthcare expenditure, and the rise in awareness related to the use of anti-rheumatics, are boosting the growth of the market in the region. MARKET INSIGHTS The Asia Pacific anti-rheumatics market is further surveyed on the basis of the markets situated in countries such as Indonesia, Japan, China, India, Australia & New Zea......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs